Antitumor effects of bisphosphonates

Area of Science:

• Oncology
• Pharmacology
• Biochemistry

Background:

• Bisphosphonates are crucial for managing skeletal complications in cancer.
• Nitrogen-containing bisphosphonates (N-BPs) inhibit protein prenylation, impacting cell function.
• N-BPs may possess direct antitumor properties beyond osteoclast inhibition.

Purpose of the Study:

• To investigate the in vitro and in vivo antitumor effects of N-BPs.
• To explore the synergistic potential of N-BPs with other antineoplastic agents.
• To evaluate the impact of N-BPs on tumor cell viability and metastatic properties.

Main Methods:

• In vitro studies assessed tumor cell adhesion, invasion, proliferation, and apoptosis.
• Animal models of bone metastases were used to evaluate bisphosphonate treatment efficacy.
• Combination therapies involving N-BPs and other agents were examined.

Main Results:

• N-BPs demonstrated significant inhibition of tumor cell adhesion and invasion in vitro.
• Higher N-BP concentrations induced antiproliferative and proapoptotic effects.
• Bisphosphonate treatment reduced osteolytic lesions and tumor burden in bone metastases models.

Conclusions:

• N-BPs exhibit direct antitumor properties and synergize with other chemotherapeutic agents.
• N-BPs can exert cytostatic effects on bone metastasis tumor cells.
• Optimization of N-BP dosing regimens is essential for maximizing their antitumor potential in vivo.